BioCentury
ARTICLE | Financial News

NovaDigm closes $14 million in tranched series B

October 4, 2013 12:34 AM UTC

NovaDigm Therapeutics Inc. (Grand Forks, N.D.) secured $14 million in a tranched series B round from new investor Rusnano, the state-funded $10 billion Russian fund, and existing investor Domain Assoc...